# FDA 483 - Jeffrey S. Overcash, MD - February 03, 2017

Source: https://www.keypedia.com/records/483/jeffrey-s-overcash-md/210f16f7-43db-43cd-b35f-f5a9273ff465

> FDA 483 for Jeffrey S. Overcash, MD on February 03, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jeffrey S. Overcash, MD
- Inspection Date: 2017-02-03
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Jeffrey S. Overcash, MD, a clinical investigator in La Mesa, CA, received an FDA Form 483 citing significant deficiencies during an inspection. The firm failed to maintain accurate case histories, with numerous discrepancies found in adverse event, medical history, and concomitant medication records. Additionally, the investigation was not conducted in accordance with the investigational plan, as required study assessments were not performed for multiple subjects.

## Related Officers

- [Investigator](https://www.keypedia.com/people/alexandra-b-pitkin/5e123821-0dd9-4a0d-ba57-f781008cda34)

Company: https://www.keypedia.com/companies/jeffrey-s-overcash-md/ac67a2af-442c-4f20-9b04-471344dadf99

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6